Pharma channel feed – Endpoints News

Pharma channel feed

FDA will allow observational studies as part of a push for real world evidence, new framework says

7 years ago

Accused of milking the CMS with co-pay kickbacks, J&J's Actelion settles case for $310M

7 years ago

Joining hunt for hep B cure, Brii Bio inks maiden deals featuring VBI, Vir, WuXi with a big appetite for more

7 years ago

In search of biotech hub glory, the Big Apple lures local startups with lab space

7 years ago

Mereo reverse merges with a flailing OncoMed and preps for a back flip onto Nasdaq

7 years ago

A last-ditch effort to derail Takeda’s $62B Shire buyout goes down in flames

7 years ago

What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs

7 years ago

FDA issues draft guidance on NASH drug development

7 years ago

Novartis gains priority review for SMA gene therapy as investors grapple with sticker shock

7 years ago

All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division

7 years ago

Finally satisfied with Ocular's manufacturing setup, FDA approves eye drug/device Dextenza

7 years ago

J&J pays $500M in cash to grab rights to a new star cancer drug at argenx

7 years ago

Spotlight on drug pricing could be catalyst for change in US biosimilar landscape

7 years ago

FDA to follow EMA with move from London to Amsterdam

7 years ago

Catalyst Pharma's LEMS drug Firdapse wins FDA nod, as regulators keep the approval engine running at record speed

7 years ago

FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals

7 years ago

Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London

7 years ago

FDA warns investigator for violating clinical hold

7 years ago

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing

7 years ago

Global syndicate backs $400M genomics R&D play in Ireland as WuXi NextCODE extends its reach into Europe

7 years ago

Trump proposal tapers Medicare protection for certain drugs if drugmakers don't temper pricing

7 years ago

Shattering an old record, FDA quickly OKs pioneering, site-agnostic cancer drug larotrectinib from Loxo and Bayer

7 years ago

After falling off a cliff, Edge Therapeutics provides cancer-focused PDS Biotech a reverse merger onto Nasdaq

7 years ago

Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months

7 years ago

First page Previous page 285 286 287288289 290 291 Next page Last page